Mode
Text Size
Log in / Sign up

Multi-component environmental control intervention shows feasibility for sleep promotion in ventilated ICU patientsSmall pilot study tests sleep environment intervention for ventilated ICU patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider this pilot study a proof of concept for implementing environmental sleep interventions in the ICU, not evidence of efficacy.

This pilot randomized controlled trial, conducted in an intensive care unit at a tertiary care teaching hospital in Santiago, Chile, was designed to assess the feasibility of implementing a multi-component environmental control intervention to promote sleep in critically ill, mechanically ventilated patients. The study enrolled 17 adult patients who had been mechanically ventilated for at least 48 hours and had received no or only superficial sedation in the preceding 24 hours. Participants were randomized to either the intervention group (n=9) or a standard care control group (n=8). The primary objective was to evaluate feasibility metrics, not to establish clinical efficacy.

The intervention consisted of three components: dynamic light therapy, auditory masking, and rationalization of nighttime care. Dynamic light therapy involved exposure to bright light during daytime hours and dim light at night. Auditory masking used white noise to dampen environmental sounds. Rationalization of nighttime care aimed to cluster nursing activities to minimize sleep disruptions. The comparator was standard ICU care, which did not include these structured environmental modifications. The intervention was delivered from randomization until ICU discharge.

The primary outcomes were feasibility measures. The enrollment rate was 94%. Retention until day three post-randomization was 78% in the intervention group (7 out of 9 patients) and 100% in the control group (8 out of 8 patients). Among the 8 intervention group participants who remained in the study until ICU discharge, all received the full intervention, indicating 100% fidelity. The 6-month post-ICU discharge follow-up rate was low at 35%. All participants who completed the study nights expressed very high satisfaction with the intervention.

Key secondary outcomes were intended to assess sleep quantity (via polysomnography and actigraphy), sleep quality (via the Richards-Campbell Sleep Questionnaire), prevalence of delirium at day three, and neuropsychological impairment at six months. However, the summary does not report any numerical results for these efficacy endpoints, as the study was not powered to detect differences and focused solely on feasibility. The absence of reported data on these secondary outcomes is a critical feature of this pilot study.

Safety and tolerability findings were not reported in the provided summary. There is no information on adverse events, serious adverse events, discontinuations due to the intervention, or general tolerability. This represents a significant gap in the available evidence from this study.

This pilot study cannot be directly compared to prior landmark efficacy trials in ICU sleep promotion or delirium prevention, as it was explicitly designed as a feasibility study. Larger randomized controlled trials, such as those testing pharmacologic sleep aids or other non-pharmacologic bundles, have reported on clinical outcomes like delirium incidence and ventilator-free days. This study's contribution is methodological, demonstrating that a complex environmental intervention can be implemented with high fidelity in a challenging ICU setting, which is a necessary precursor to a future definitive trial.

Key methodological limitations are inherent to its pilot and feasibility design. The sample size of 17 patients is very small. The study was not powered to detect differences in clinical outcomes like sleep architecture, delirium, or long-term cognitive function. The very low 6-month follow-up rate (35%) severely limits any assessment of long-term neuropsychological outcomes. The single-center setting in Chile may limit generalizability to other healthcare systems and ICU environments. The lack of reported safety data is another important limitation.

The clinical implication is that a multi-component environmental control intervention for sleep promotion is feasible to implement in a ventilated ICU population with minimal sedation. The high fidelity and participant satisfaction are encouraging for future research. For current practice, this study does not provide evidence to change clinical care, as it was not an efficacy trial. It does, however, provide a template for how such an intervention could be operationalized in an ICU setting.

Several important questions remain unanswered. The efficacy of this specific intervention bundle on objectively measured sleep quality and quantity is unknown. Its impact on short-term clinical outcomes like delirium prevalence or duration of mechanical ventilation is unknown. The long-term effect on neuropsychological function at 6 months post-ICU discharge could not be assessed due to high attrition. The safety profile and potential unintended consequences of the intervention components were not evaluated. Finally, the cost-effectiveness and resource requirements for implementing such an intervention on a larger scale are unclear. A fully powered, multicenter randomized controlled trial is required to answer these efficacy and safety questions.

This research matters to people who have loved ones in intensive care units (ICUs) and to patients who have survived critical illness. Being on a ventilator in the ICU is extremely stressful, and poor sleep is common due to constant noise, bright lights, and frequent medical checks. This can potentially affect recovery both in the hospital and long after going home. The study explored whether making the ICU environment more sleep-friendly is a practical idea that patients and staff can accept.

The researchers conducted a small pilot study with 17 adult patients in a Chilean ICU. All patients were on mechanical ventilators for at least 48 hours and were receiving little to no sedating medication. The goal was not to prove the intervention worked, but to see if it was possible to do the study properly. Nine patients received a special sleep-promoting environment, which included dynamic light therapy (lights that mimic natural daylight and darkness), auditory masking (using sound to cover up hospital noises), and rationalization of nighttime care (grouping necessary checks to minimize sleep disruptions). Eight other patients received standard ICU care for comparison.

The main findings were about whether the study could be done, not about patient health. The researchers successfully enrolled 94% of eligible patients. Most patients (78% in the intervention group and 100% in the control group) stayed in the study for the first three days in the ICU. The team was able to deliver the full sleep environment package to all patients assigned to receive it. Patients who experienced the intervention reported very high satisfaction with it. However, a major challenge was long-term follow-up; only 35% of patients were reachable for a check-up six months after leaving the ICU, which makes it hard to study long-term effects.

No safety concerns, adverse events, or problems with patients tolerating the intervention were reported in this small study. The intervention involved non-invasive changes to light and sound, which generally carry a low risk of harm.

It is crucial not to overreact to this single study. This was a pilot feasibility study with only 17 participants. Its main purpose was to test whether a larger, more definitive trial would be possible to run. It was not designed, and is far too small, to show whether this environmental intervention actually helps patients sleep better, reduces delirium, or improves long-term brain function. The very low rate of successful 6-month follow-up (35%) is a significant limitation for studying any potential long-term benefits.

Realistically, for patients and families right now, this study means that researchers are exploring gentle, non-drug ways to possibly improve the ICU experience. The high patient satisfaction is encouraging. However, no changes to standard care are recommended based on this research alone. The value of this study is that it suggests a larger, more robust clinical trial is feasible and worth conducting. Such a future trial would need to include hundreds of patients to reliably determine if creating a more sleep-friendly ICU environment leads to meaningful improvements in patient recovery.

What this means for you:
A small pilot study found a sleep-friendly ICU environment was feasible and satisfactory, but larger trials are needed to see if it helps.

Study Details

Study typeRct
Sample sizen = 122
EvidenceLevel 2
Follow-up6.0 mo
PublishedApr 2026
View Original Abstract ↓
OBJECTIVES: To evaluate the feasibility of implementing a multi-component intervention in the ICU to promote sleep in critically ill patients. TRIAL DESIGN: A prospective, two-parallel-group, unblinded, pilot randomized controlled trial. METHODS: Adult patients ventilated for at least 48 h with no or superficial sedation in the past 24 h were recruited. They were randomized to receive a multi-component ICU environmental control intervention (dynamic light therapy, auditory masking, and rationalization of nighttime care) or standard care. A family member of each participant consented to the study. MAIN OUTCOME MEASURES: The primary outcomes were the feasibility of enrolling and retaining participants and the fidelity of the intervention. Secondary outcomes were sleep quantity (assessed by polysomnography and actigraphy) and sleep quality (assessed by Richards-Campbell Sleep Questionnaire), the prevalence of delirium at day three post-randomization, and neuropsychological impairment at six months post-ICU discharge. SETTING: An intensive care unit in a tertiary care teaching hospital in Santiago, Chile. RESULTS: 122 patients were screened; 17 were randomized, 9 to intervention and 8 to control. 78% (7) and 100% (8) stayed in ICU until day three. All 8 in the intervention group received the full intervention until ICU discharge. The enrollment rate was 94%. The 6-month follow-up rate was 35%, as some patients died. All participants who completed the study nights expressed very high satisfaction. CONCLUSIONS: This pilot study demonstrates the feasibility and acceptability of the intervention and informs methodological refinements for a future trial. IMPLICATIONS FOR CLINICAL PRACTICE: Implementing a multi-component environmental control intervention in intensive care units could improve short- and long-term outcomes in ventilated patients; however, further high-quality efficacy trials are required.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.